551 related articles for article (PubMed ID: 18374982)
1. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
[TBL] [Abstract][Full Text] [Related]
2. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
[TBL] [Abstract][Full Text] [Related]
3. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
Cantaert T; Teitsma C; Tak PP; Baeten D
Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
[TBL] [Abstract][Full Text] [Related]
4. Suppressive oligonucleotides protect against collagen-induced arthritis in mice.
Dong L; Ito S; Ishii KJ; Klinman DM
Arthritis Rheum; 2004 May; 50(5):1686-9. PubMed ID: 15146440
[TBL] [Abstract][Full Text] [Related]
5. [Animal models for bone and joint disease. CIA, CAIA model].
Hirose J; Tanaka S
Clin Calcium; 2011 Feb; 21(2):253-9. PubMed ID: 21289422
[TBL] [Abstract][Full Text] [Related]
6. Collagen-induced arthritis.
Brand DD; Latham KA; Rosloniec EF
Nat Protoc; 2007; 2(5):1269-75. PubMed ID: 17546023
[TBL] [Abstract][Full Text] [Related]
7. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
[TBL] [Abstract][Full Text] [Related]
8. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
[TBL] [Abstract][Full Text] [Related]
9. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
Tellander AC; Michaëlsson E; Brunmark C; Andersson M
J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
[TBL] [Abstract][Full Text] [Related]
10. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is associated with anti-CII B-cell activation.
Holmdahl R; Vingsbo C; Malmström V; Jansson L; Holmdahl M
J Autoimmun; 1994 Dec; 7(6):739-52. PubMed ID: 7888032
[TBL] [Abstract][Full Text] [Related]
11. Enhanced susceptibility to low-dose collagen-induced arthritis in CR1/2-deficient female mice--possible role of estrogen on CR1 expression.
Nilsson KE; Andrén M; Diaz de Ståhl T; Kleinau S
FASEB J; 2009 Aug; 23(8):2450-8. PubMed ID: 19351702
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
13. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.
Tada Y; Koarada S; Morito F; Ushiyama O; Haruta Y; Kanegae F; Ohta A; Ho A; Mak TW; Nagasawa K
Arthritis Rheum; 2003 Nov; 48(11):3280-90. PubMed ID: 14613294
[TBL] [Abstract][Full Text] [Related]
15. Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis.
Thiele GM; Duryee MJ; Dusad A; Hunter CD; Lacy JP; Anderson DR; Wang D; O'Dell JR; Mikuls TR; Klassen LW
Int Immunopharmacol; 2012 Aug; 13(4):424-31. PubMed ID: 22626832
[TBL] [Abstract][Full Text] [Related]
16. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen.
Bajtner E; Nandakumar KS; Engström A; Holmdahl R
Arthritis Res Ther; 2005; 7(5):R1148-57. PubMed ID: 16207332
[TBL] [Abstract][Full Text] [Related]
17. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors.
Noorchashm H; Moore DJ; Lieu YK; Noorchashm N; Schlachterman A; Song HK; Barker CF; Naji A
Cell Immunol; 1999 Jul; 195(1):75-9. PubMed ID: 10433799
[TBL] [Abstract][Full Text] [Related]
19. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
Morgan ME; Sutmuller RP; Witteveen HJ; van Duivenvoorde LM; Zanelli E; Melief CJ; Snijders A; Offringa R; de Vries RR; Toes RE
Arthritis Rheum; 2003 May; 48(5):1452-60. PubMed ID: 12746920
[TBL] [Abstract][Full Text] [Related]
20. Oxidative modification of type II collagen differentially affects its arthritogenic and tolerogenic capacity in experimental arthritis.
Marcinkiewicz J; Biedroń R; Maresz K; Kwaśny-Krochin B; Bobek M; Kontny E; Maśliński W; Chain B
Arch Immunol Ther Exp (Warsz); 2004; 52(4):284-91. PubMed ID: 15467493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
